Protein kinase-CK2 inhibition as a potential treatment for multiple myeloma

被引：0
|
作者：
Turner, Joel G.
Dawson, Jana L.
Ciaravino, Elizabeth J.
Koomen, John M.
Sullivan, Daniel M.
机构：
来源：
CANCER RESEARCH | 2010年 / 70卷
关键词：
D O I：
10.1158/1538-7445.AM10-725
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
725
引用
收藏
页数：4
相关论文
共 50 条
  • [21] Inhibition of Protein Kinase CK2 by Flavonoids and Tyrphostins. A Structural Insight
    Lolli, Graziano
    Cozza, Giorgio
    Mazzorana, Marco
    Tibaldi, Elena
    Cesaro, Luca
    Donella-Deana, Arianna
    Meggio, Flavio
    Venerando, Andrea
    Franchin, Cinzia
    Sarno, Stefania
    Battistutta, Roberto
    Pinna, Lorenzo A.
    BIOCHEMISTRY, 2012, 51 (31) : 6097 - 6107
  • [22] Biochemical and cellular mechanism of protein kinase CK2 inhibition by deceptive curcumin
    Cozza, Giorgio
    Zonta, Francesca
    Dalle Vedove, Andrea
    Venerando, Andrea
    Dall'Acqua, Stefano
    Battistutta, Roberto
    Ruzzene, Maria
    Lolli, Graziano
    FEBS JOURNAL, 2020, 287 (09) : 1850 - 1864
  • [23] Aurora-Kinase Inhibition for Tailored Risk-Adapted Treatment of Multiple Myeloma
    Hose, D.
    Reme, T.
    Meissner, T.
    Moreaux, J.
    Seckinger, A.
    Lewis, J.
    Benes, V.
    Benner, A.
    Hundemer, M.
    Hielscher, T.
    Shaughnessy, J. D., Jr.
    Barlogie, B.
    Neben, K.
    Kraemer, A.
    Hillengass, J.
    Bertsch, U.
    Jauch, A.
    De Vos, J.
    Rossi, J. F.
    Moehler, T.
    Blake, J.
    Zimmermann, J.
    Klein, B.
    Goldschmidt, H.
    CLINICAL LYMPHOMA & MYELOMA, 2009, 9 : S97 - S98
  • [24] Protein Kinase CK2 in Health and DiseaseCellular functions of Protein kinase CK2: a dynamic affair
    O. Filhol
    C. Cochet
    Cellular and Molecular Life Sciences, 2009, 66 : 1830 - 1839
  • [25] Inhibition of Sphingosine Kinase 2 Enhances Immunotherapy in Mouse Model of Multiple Myeloma
    Kang, Yubin
    Wang, Xiaobei
    Wu, Jian
    Jabbar, Shaima
    Jiang, Chongming Tom
    Shen, Xiling
    Ogretmen, Besim
    BLOOD, 2023, 142
  • [26] INHIBITION OF SPHINGOSINE KINASE 2 RESENSITISES BORTEZOMIB-RESISTANT MULTIPLE MYELOMA
    Bennett, Melissa
    Tea, Melinda
    Gliddon, Briony
    Toubia, John
    Orlowski, Robert
    Wallington-Beddoe, Craig
    Pitson, Stuart
    EXPERIMENTAL HEMATOLOGY, 2019, 76 : S58 - S58
  • [27] Protein Kinase CK2 and Angiogenesis
    Montenarh, Mathias
    ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 2014, 23 (02): : 153 - 158
  • [28] Inhibition of adenosine monophosphate-activated protein kinase induces apoptosis in multiple myeloma cells
    Baumann, Philipp
    Mandl-Weber, Sonja
    Emmerich, Bertold
    Straka, Christian
    Schmidmaier, Ralf
    ANTI-CANCER DRUGS, 2007, 18 (04) : 405 - 410
  • [29] Sphingosine kinase 2 and multiple myeloma
    Pyne, Nigel J.
    Pyne, Susan
    ONCOTARGET, 2017, 8 (27): : 43596 - 43597
  • [30] Protein kinase CK2: a potential therapeutic target for diverse human diseases
    Christian Borgo
    Claudio D’Amore
    Stefania Sarno
    Mauro Salvi
    Maria Ruzzene
    Signal Transduction and Targeted Therapy, 6
12345